Search research articles
Contact Us
Filters
Showing results (21-30 of 69) with videos related to
Page
of 7
Sort By:
Clinical Drug Investigation
|
July 16, 2014
Effect of rifampicin on the pharmacokinetics of lenvatinib in healthy adults
Robert C Shumaker, Jagadeesh Aluri, Jean Fan, et al.
Cancer Chemotherapy and Pharmacology
|
March 25, 2014
Effect of lenvatinib (E7080) on the QTc interval: results from a thorough QT study in healthy volunteers
Robert C Shumaker, Meijian Zhou, Min Ren, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Spatiotemporal transcriptomic analysis during cold ischemic injury to the murine kidney reveals compartment-specific changes
Srujan Singh, Shishir Kumar Patel, Ryo Matsuura, et al.
Genome Biology
|
June 20, 2026
Spatiotemporal transcriptomic analysis during cold ischemic injury to the murine kidney reveals compartment-specific changes
Srujan Singh, Shishir Kumar Patel, Ryo Matsuura, et al.
Frontiers in Psychology
|
August 25, 2023
Are "outsiders" in? Exploring the impact of outsourced workers' perceived insider status and job value status on job performance
Jean Fan Yang, Wei Shi, Erica Wen Chen, et al.
Bioinformatics (Oxford, England)
|
June 21, 2024
SEraster: a rasterization preprocessing framework for scalable spatial omics data analysis
Gohta Aihara, Kalen Clifton, Mayling Chen, et al.
Nature Communications
|
December 8, 2023
STalign: Alignment of spatial transcriptomics data using diffeomorphic metric mapping
Kalen Clifton, Manjari Anant, Gohta Aihara, et al.
Biorxiv : the Preprint Server for Biology
|
April 24, 2023
Alignment of spatial transcriptomics data using diffeomorphic metric mapping
Kalen Clifton, Manjari Anant, Gohta Aihara, et al.
Nature Methods
|
November 20, 2019
Fast, sensitive and accurate integration of single-cell data with Harmony
Ilya Korsunsky, Nghia Millard, Jean Fan, et al.
Investigational New Drugs
|
May 30, 2018
Phase I dose-escalation trial of afatinib, an irreversible ErbB family blocker, in combination with gemcitabine or docetaxel in patients with relapsed or refractory solid tumors
Sandrine Hiret, Nicolas Isambert, Carlos Gomez-Roca, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 69) with videos related to
Sort By:
Page
of 7
Clinical Drug Investigation
|
July 16, 2014
Effect of rifampicin on the pharmacokinetics of lenvatinib in healthy adults
Robert C Shumaker, Jagadeesh Aluri, Jean Fan, et al.
Cancer Chemotherapy and Pharmacology
|
March 25, 2014
Effect of lenvatinib (E7080) on the QTc interval: results from a thorough QT study in healthy volunteers
Robert C Shumaker, Meijian Zhou, Min Ren, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Spatiotemporal transcriptomic analysis during cold ischemic injury to the murine kidney reveals compartment-specific changes
Srujan Singh, Shishir Kumar Patel, Ryo Matsuura, et al.
Genome Biology
|
June 20, 2026
Spatiotemporal transcriptomic analysis during cold ischemic injury to the murine kidney reveals compartment-specific changes
Srujan Singh, Shishir Kumar Patel, Ryo Matsuura, et al.
Frontiers in Psychology
|
August 25, 2023
Are "outsiders" in? Exploring the impact of outsourced workers' perceived insider status and job value status on job performance
Jean Fan Yang, Wei Shi, Erica Wen Chen, et al.
Bioinformatics (Oxford, England)
|
June 21, 2024
SEraster: a rasterization preprocessing framework for scalable spatial omics data analysis
Gohta Aihara, Kalen Clifton, Mayling Chen, et al.
Nature Communications
|
December 8, 2023
STalign: Alignment of spatial transcriptomics data using diffeomorphic metric mapping
Kalen Clifton, Manjari Anant, Gohta Aihara, et al.
Biorxiv : the Preprint Server for Biology
|
April 24, 2023
Alignment of spatial transcriptomics data using diffeomorphic metric mapping
Kalen Clifton, Manjari Anant, Gohta Aihara, et al.
Nature Methods
|
November 20, 2019
Fast, sensitive and accurate integration of single-cell data with Harmony
Ilya Korsunsky, Nghia Millard, Jean Fan, et al.
Investigational New Drugs
|
May 30, 2018
Phase I dose-escalation trial of afatinib, an irreversible ErbB family blocker, in combination with gemcitabine or docetaxel in patients with relapsed or refractory solid tumors
Sandrine Hiret, Nicolas Isambert, Carlos Gomez-Roca, et al.
Page
of 7